# US 2013/0280745 A1 · High-throughput, sensitive detection of glucose-6-phosphate dehydrogenase

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0280745 A1
- Document ID: US20130280745A1
- Status: Published application
- Kind: A1
- Application number: 13/989,323
- Filed: 2011-11-17
- Published: 2013-10-24
- Earliest claimed: 2010-11-24
- Assignees: DH Technologies Development Pte. Ltd.
- Inventors: Bruno Casetta
- Web page: https://patentgrep.com/patent/US20130280745A1

## CPC

- C12Q 1/32: involving dehydrogenase
- C12Q 1/54: involving glucose or galactose
- G01N 2560/00: Chemical aspects of mass spectrometric analysis of biological material
- G01N 2800/22: Haematology
- G01N 2800/368: Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Provided herein are methods for determining an amount of glucose-6-phosphate dehydrogenase (“G6PDH”) in a biological sample. Also provided herein are methods for detecting G6PDH deficiency, as well as diagnosing G6PDH-associated disorders, such as acute hemolytic anemia and pre-eclampsia.

## Claims

### Claim 1

A high throughput method for detecting an amount of G6PDH in a biological sample, the method comprising:
reacting a biological sample with G6P and NADP in the presence of a surfactant and a buffer under suitable conditions to form 6-phosphogluconic acid;
quenching the biological sample to form a quenched sample; and
detecting by mass spectrometry a presence or amount of 6-phosphogluconic acid in the quenched sample,
wherein the amount of 6-phosphogluconic acid in the quenched sample is related to the amount of G6PDH in the biological sample.

### Claim 2 (depends on 1)

The method of claim 1, wherein the quenching is accomplished using an enzyme denaturant.

### Claim 3

(canceled)

### Claim 4 (depends on 1)

The method of claim 1, wherein the mass spectrometry is accomplished using a mass spectrometer equipped with a thermally assisted electrospray ionization probe.

### Claim 5 (depends on 1)

The method of claim 1, wherein the mass spectrometry is accomplished using a mass spectrometer equipped with a reversed phase liquid chromatography column.

### Claim 6 (depends on 1)

The method of claim 1, wherein the detecting, occurs in less than about 5 minutes.

### Claim 7

(canceled)

### Claim 8 (depends on 1)

The method of claim 1, wherein the method allows for detection of about 0.01 milliUnits of G6PDH or less.

### Claim 9 (depends on 1)

The method of claim 1, wherein the detecting is not substantially affected by fluctuations in temperature.

### Claim 10

A method for detecting G6PDH deficiency in a subject, the method comprising
determining by mass spectrometry an amount of G6PDH in a biological sample from a subject; and
comparing the amount of G6PDH in the biological sample to an appropriate control, wherein G6PDH deficiency is detected when the amount of G6PDH in the sample is less than the appropriate control.

### Claim 11

(canceled)

### Claim 12

(canceled)

### Claim 13 (depends on 10)

The method of claim 10, wherein an amount of G6PDH in the sample which is 10% less than the control indicates a G6PDH deficiency in the subject.

### Claim 14 (depends on 10)

The method of claim 10, wherein an amount of G6PDH in the sample which is 25% less than the control indicates a G6PDH deficiency in the subject.

### Claim 15 (depends on 10)

The method of claim 10, wherein an amount of G6PDH in the sample which is 50% less than the control indicates a G6PDH deficiency in the subject.

### Claim 16 (depends on 10)

A method for diagnosing acute hemolytic anemia in a subject, the method comprising
detecting G6PDH deficiency in a subject in accordance with the method of claim 10, wherein a G6PDH deficiency in the subject indicates acute hemolytic anemia in the subject.

### Claim 17 (depends on 16)

The method of claim 16, wherein an amount of G6PDH in the sample which is 25% less than the control indicates acute hemolytic anemia in the subject.

### Claim 18 (depends on 10)

A method for diagnosing pre-eclampsia in as subject, the method comprising
detecting G6PDH deficiency in a subject in accordance with the method of claim 10, wherein a G6PDH deficiency in the subject indicates pre-eclampsia in the subject.

### Claim 19 (depends on 18)

The method of claim 18, wherein an amount of G6PDH in the sample which is 25% less than the control indicates pre-eclampsia in the subject.

### Claim 20 (depends on 10)

A prognostic method for increased mortality and/or morbidity resulting from pre-eclampsia or acute hemolytic anemia in a subject, comprising
detecting G6PDH deficiency in a subject in accordance with the method of claim 10, wherein an amount of the G6PDH in the biological sample which is 50% or less than the control indicates a prognosis of increased mortality and/or morbidity in the subject.

### Claim 21 (depends on 20)

The method of claim 20, wherein the appropriate control is a control based upon G6PDH levels in a normal population.

### Claim 22 (depends on 20)

The method of claim 20, further comprising:
reacting the biological sample with G6P and N ADP in the presence of surfactant and a buffer under suitable conditions to form 6-phosphogluconic acid;
quenching the biological sample to form a quenched sample; and
detecting by mass spectrometry a presence or amount of 6-phosphogluconic acid in the quenched sample,
wherein the amount of 6-phosphogluconic acid it the quenched sample is related to the amount of G6PDH in the biological sample.

### Claim 23

(canceled)

### Claim 24

A kit for detecting an amount of G6PDH in a biological sample, the kit comprising:
glucose-6-phosphate,
nicotinamide adenine dinucleotide phosphate,
optionally a buffer,
optionally a surfactant, and
instructions for preparing a reaction mixture that facilitates a reaction of nicotinamide adenine dinucleotide phosphate, glucose-6-phosphate and G6PDH.

### Claim 25 (depends on 24)

The kit of claim 24, further comprising at least one of an enzyme denaturant, instructions for preparing a sample for analysis in a mass spectrometer, and a calibration curve which comprises a plot of [6-phosphogluconic acid/glucose-6-phosphate area] versus milliUnits of G6PDH.

### Claim 26

(canceled)

### Claim 27

(canceled)
